Tempus AI announced a collaboration with Flatiron Health to integrate its comprehensive genomic testing directly into Flatiron's cloud-based Electronic Medical Record (EMR) platform, OncoEMR®, through the Molecular Profiling Integration (MPI). This integration provides oncologists with seamless access to Tempus's suite of testing options.
Flatiron's MPI, a two-way integration, will allow 4,200 providers at over 800 community-based cancer care locations across the U.S. to order and receive results from Tempus directly within the OncoEMR workflow. This significantly reduces administrative burden and improves the experience for care providers.
A key feature of this integration is unified ordering, with a single order form deployed across all MPI-participating practices. This integration provides comprehensive access to Tempus tests, including xT, xR, xF/xF+, xG/xG+ Ambry, xM/xM (NeXT Personal Dx), and several AI-enabled, algorithmic, add-on tests.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.